QUILT-3.035: Relapse Prophylaxis With IL-15 Super Agonist ALT-803 in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome Following Allogeneic Stem Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2017
At a glance
- Drugs ALT 803 (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms QUILT-3.035
- 13 Apr 2017 Status changed from not yet recruiting to recruiting.
- 13 Feb 2017 Planned initiation date changed from 1 Jan 2017 to 1 Apr 2017.
- 14 Dec 2016 New trial record